These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29764749)

  • 1. Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease.
    Naito M; Kurahara Y; Yoshida S; Ikegami N; Kobayashi T; Minomo S; Tachibana K; Tsuyuguchi K; Hayashi S; Suzuki K
    Respir Investig; 2018 Jul; 56(4):326-331. PubMed ID: 29764749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.
    Takeda K; Imamura Y; Takazono T; Yoshida M; Ide S; Hirano K; Tashiro M; Saijo T; Kosai K; Morinaga Y; Nakamura S; Kurihara S; Tsukamoto M; Miyazaki T; Tashiro T; Kohno S; Yanagihara K; Izumikawa K
    Med Mycol; 2016 Feb; 54(2):120-7. PubMed ID: 26531100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and microbiological features of patients with pulmonary nontuberculous mycobacterial infection].
    To M; Yazawa J; Hitani A; Sagara H; Kano I; Haruki K
    Rinsho Byori; 2013 Aug; 61(8):671-8. PubMed ID: 24218763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease.
    Furuuchi K; Ito A; Hashimoto T; Kumagai S; Ishida T
    J Infect Chemother; 2018 Aug; 24(8):654-659. PubMed ID: 29705392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.
    Jhun BW; Jung WJ; Hwang NY; Park HY; Jeon K; Kang ES; Koh WJ
    PLoS One; 2017; 12(11):e0188716. PubMed ID: 29190796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease.
    Shirai T; Furuuchi K; Fujiwara K; Nakamoto K; Tanaka Y; Ishii H; Yoshiyama T; Yoshimori K; Takizawa H; Sasaki Y; Kurashima A; Ohta K; Morimoto K
    Respir Med; 2020 May; 166():105955. PubMed ID: 32321630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of chronic pulmonary aspergillosis: A retrospective cohort of 264 patients from Japan.
    Kimura Y; Sasaki Y; Suzuki J; Suzuki J; Igei H; Suzukawa M; Matsui H
    PLoS One; 2021; 16(4):e0249455. PubMed ID: 33793645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality in chronic pulmonary aspergillosis.
    Lowes D; Al-Shair K; Newton PJ; Morris J; Harris C; Rautemaa-Richardson R; Denning DW
    Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28179437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011.
    de Mello KG; Mello FC; Borga L; Rolla V; Duarte RS; Sampaio EP; Holland SM; Prevots DR; Dalcolmo MP
    Emerg Infect Dis; 2013 Mar; 19(3):393-9. PubMed ID: 23745217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study.
    Gommans EP; Even P; Linssen CF; van Dessel H; van Haren E; de Vries GJ; Dingemans AM; Kotz D; Rohde GG
    Respir Med; 2015 Jan; 109(1):137-45. PubMed ID: 25464905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Impact of Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Pulmonary Disease and Role of Computed Tomography in the Diagnosis.
    Maruguchi N; Tanaka E; Okagaki N; Tanaka Y; Sakamoto H; Takeda A; Yamamoto R; Nakamura S; Matsumura K; Ueyama M; Ikegami N; Kaji Y; Hashimoto S; Hajiro T; Taguchi Y
    Intern Med; 2023 Nov; 62(22):3291-3298. PubMed ID: 36927976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
    Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
    Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors.
    Andréjak C; Thomsen VØ; Johansen IS; Riis A; Benfield TL; Duhaut P; Sørensen HT; Lescure FX; Thomsen RW
    Am J Respir Crit Care Med; 2010 Mar; 181(5):514-21. PubMed ID: 20007929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
    Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
    Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pulmonary aspergillosis as a sequel to lobectomy for lung cancer.
    Tamura A; Suzuki J; Fukami T; Matsui H; Akagawa S; Ohta K; Hebisawa A; Takahashi F
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):650-6. PubMed ID: 26323287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical findings in relation to mortality in non-tuberculous mycobacterial infections: patients with Mycobacterium avium complex have better survival than patients with other mycobacteria.
    Kotilainen H; Valtonen V; Tukiainen P; Poussa T; Eskola J; Järvinen A
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1909-18. PubMed ID: 26155783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical analysis of patients with pulmonary nontuberculous mycobacterial disease complicated by pneumothorax.
    Kobashi Y; Mouri K; Obase Y; Kato S; Oka M
    Intern Med; 2013; 52(22):2511-5. PubMed ID: 24240789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of non-tuberculous mycobacteriosis cases complicated with pulmonary aspergillosis].
    Ishikawa S; Yano S; Kadowaki T; Wakabayashi K; Kimura M; Kobayashi K; Ikeda T
    Kekkaku; 2011 Sep; 86(9):781-5. PubMed ID: 22111386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.